view:  full / summary

Musings on Anti-Xa Activity Levels

Posted by gulseth.michael on March 8, 2017 at 1:30 PM Comments comments (0)


Recently, there was a good article in AJHP on dealing with transitions from oral Xa inhibitors to heparin. You can read it at AJHP 2016; 73:2037-41

This has piqued a lot of my interest in this subject since we actively use novel drug levels like dabigatran, rivaroxaban, and apixaban levels. We have published on this in the past. See:


Recently, I have been seeing a lack of understanding on how to hand...

Read Full Post »

2017 ISMP Antithrombotic Therapy Self-Assessment

Posted by gulseth.michael on February 17, 2017 at 11:30 AM Comments comments (0)

Hello all!

Excited to announce the realease of the new, 2017 ISMP Medication Safety Self-Assessment for Antithrombotic Therapy.  I would strongly encourage all practitioners who work in health-systems to review these new guidelines so we can keep our patients safe.  They do cover direct acting oral anticoagulants.

Thank you, as always, to the leadershp shown by ISMP!

Michael P. Gusleth, Phar...

Read Full Post »